Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Callahan

Showing results (311-320 of 437) with videos related to

Pageof 44
Sort By:
JAMA|February 10, 1989
Passive smoking on commercial airline flightsM E Mattson, G Boyd, D Byar, et al.
Arthritis|November 22, 2013
Association of self-efficacy and outcome expectations with physical activity in adults with arthritisThelma J Mielenz, Kathryn L Kubiak-Rizzone, Kimberly J Alvarez, et al.
Molecular Pharmacology|June 18, 2002
SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7Gareth J Inman, Francisco J Nicolás, James F Callahan, et al.
The Journal of Bone and Joint Surgery. American Volume|January 8, 2016
Angiotensin-(1-7) Attenuates Skeletal Muscle Fibrosis and Stiffening in a Mouse Model of Extremity Sarcoma Radiation TherapyJeffrey S Willey, Daniel N Bracey, Patricia E Gallagher, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2004
Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IkappaB Kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell ProliferationPatricia L Podolin, James F Callahan, Brian J Bolognese, et al.
Arthritis and Rheumatism|October 6, 2011
Microarray analysis reveals age-related differences in gene expression during the development of osteoarthritis in miceRichard F Loeser, Amy L Olex, Margaret A McNulty, et al.
JAMA|December 11, 1999
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral ThromboembolismA Furlan, R Higashida, L Wechsler, et al.
Arthritis Research & Therapy|March 20, 2010
Limited educational attainment and radiographic and symptomatic knee osteoarthritis: a cross-sectional analysis using data from the Johnston County (North Carolina) Osteoarthritis ProjectLeigh F Callahan, Jack Shreffler, Bernadette C Siaton, et al.
BMC Musculoskeletal Disorders|January 13, 2016
Socioeconomic factors and self-reported health outcomes in African Americans with rheumatoid arthritis from the Southeastern United States: the contribution of childhood socioeconomic statusAntoine R Baldassari, Rebecca J Cleveland, My-Linh N Luong, et al.
European Journal of Anaesthesiology|September 29, 2025
Neuromuscular, haemodynamic, and autonomic effects of a fast-onset, long-acting, nondepolarising, carborane neuromuscular blocking agent compared to rocuronium in ratsNoah J Timko, Tammer N Ghaly, Lalit N Goswami, et al.
Pageof 44

Showing results (311-320 of 437) with videos related to

Sort By:
Pageof 44
JAMA|February 10, 1989
Passive smoking on commercial airline flightsM E Mattson, G Boyd, D Byar, et al.
Arthritis|November 22, 2013
Association of self-efficacy and outcome expectations with physical activity in adults with arthritisThelma J Mielenz, Kathryn L Kubiak-Rizzone, Kimberly J Alvarez, et al.
Molecular Pharmacology|June 18, 2002
SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7Gareth J Inman, Francisco J Nicolás, James F Callahan, et al.
The Journal of Bone and Joint Surgery. American Volume|January 8, 2016
Angiotensin-(1-7) Attenuates Skeletal Muscle Fibrosis and Stiffening in a Mouse Model of Extremity Sarcoma Radiation TherapyJeffrey S Willey, Daniel N Bracey, Patricia E Gallagher, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2004
Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IkappaB Kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell ProliferationPatricia L Podolin, James F Callahan, Brian J Bolognese, et al.
Arthritis and Rheumatism|October 6, 2011
Microarray analysis reveals age-related differences in gene expression during the development of osteoarthritis in miceRichard F Loeser, Amy L Olex, Margaret A McNulty, et al.
JAMA|December 11, 1999
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral ThromboembolismA Furlan, R Higashida, L Wechsler, et al.
Arthritis Research & Therapy|March 20, 2010
Limited educational attainment and radiographic and symptomatic knee osteoarthritis: a cross-sectional analysis using data from the Johnston County (North Carolina) Osteoarthritis ProjectLeigh F Callahan, Jack Shreffler, Bernadette C Siaton, et al.
BMC Musculoskeletal Disorders|January 13, 2016
Socioeconomic factors and self-reported health outcomes in African Americans with rheumatoid arthritis from the Southeastern United States: the contribution of childhood socioeconomic statusAntoine R Baldassari, Rebecca J Cleveland, My-Linh N Luong, et al.
European Journal of Anaesthesiology|September 29, 2025
Neuromuscular, haemodynamic, and autonomic effects of a fast-onset, long-acting, nondepolarising, carborane neuromuscular blocking agent compared to rocuronium in ratsNoah J Timko, Tammer N Ghaly, Lalit N Goswami, et al.
Pageof 44